Skip to main content
HeartCited

Lycopene Şekiller

6 hakemli araştırmalardan görseller

Tümü Coenzyme Q10 (CoQ10) Vitamin D Folate (Vitamin B9) Magnesium Potassium Calcium Selenium Resveratrol Quercetin Lycopene Berberine
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 2
Figure 2 Diagram

Introductory overview of the carotenoid compounds evaluated for neuroprotective effects in Alzheimer's disease. The review examines how these dietary pigments may counteract neurodegeneration through antioxidant and anti-inflammatory pathways.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 1. Alzheimer’s disease KEGG pathway (hsa05010; Alzheimer disease—Homo sapiens (human)) generated online at https://www.genome.jp/kegg-bin/show_pathway?hsa05010, accessed on 8 March 2024) [115].
Figure 3 Diagram

KEGG pathway map (hsa05010) illustrating the molecular cascade involved in Alzheimer's disease pathogenesis in humans. The diagram highlights potential intervention points where carotenoid compounds may modulate amyloid-beta accumulation, tau phosphorylation, and neuroinflammatory signaling.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 7
Figure 7 Chart

Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

α-,β-cryptoxanthin is a source of vitamin A due to the fact that it has an unsubstituted β ring, similar to α-, β-, and γ-carotene. In the body, it is enzymatically cleaved with the help of (BCO1) and (BCO2) to retinol, retinal, and retinoic acid, which i
Figure 22 Diagram

Alpha- and beta-cryptoxanthin serve as provitamin A sources due to their unsubstituted beta-ring structure. The review discusses their potential role in Alzheimer's disease prevention through both antioxidant activity and vitamin A metabolite production in neural tissue.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 2
Figure 2 Chart

Statistical analysis from research investigating dietary supplements and prevention of preeclampsia, comparing treatment groups and control conditions.

Dietary supplements and prevention of preeclampsia.

Fig. 1 Dietary reference intakes. Schematic diagram illustrating the risks of nutrient inadequacy and adverse effects
Figure 3 Diagram

Fig. 1 Dietary reference intakes.

Dietary supplements and prevention of preeclampsia.